GlucoTrack, Inc. (GCTK) vs NexGel, Inc. (NXGL)
GlucoTrack, Inc. and NexGel, Inc. are both Medical Instruments & Supplies companies. NexGel, Inc. is the larger, with a market value of $3.0M against $1.9M — 1.6× the size. NexGel, Inc. grew revenue faster over the last twelve months: 3.38% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −51.3%) and the higher return on invested capital (0.00% vs −45.3%). Across the 17 metrics below, NexGel, Inc. leads on 10 and GlucoTrack, Inc. on 7.
Valuation
Profitability
| Metric | GCTK | NXGL | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 0.00% | 35.08% | 54.62% |
| Operating margin | 0.00% | (44.77%) | 1.64% |
| Net margin | 0.00% | (51.26%) | 0.00% |
| Free cash flow margin | 0.00% | (27.66%) | 1.61% |
| Return on equity | (620.63%) | (117.57%) | 0.00% |
| Return on assets | (272.48%) | (34.21%) | 0.00% |
| Return on invested capital | 0.00% | (45.29%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack